SITC Archive Library

SITC 26th Annual Meeting Summit on Cell Therapy for Cancer
November 1-2, 2011
Bethesda North Marriott Hotel & Convention Center
North Bethesda, MD

Program Organizers
David F. Stroncek, MD - National Institutes of Health
John O'Shea, MD - National Institutes of Arthritis and Musculosketetal and Skin Diseases
Cornelius J.M. Melief, MD, PhD - Leiden University Medical Center

Program Summary
The Summit on Cell Therapy for Cancer will include dynamic discussions and lectures by leaders in the field to provide an in-depth review of the state-of-the-art of cell therapy as a cancer immunotherapy. The day and a half program will include presentations on the latest research on induced pluripotent stem cells, reprogramming immune cells, and translational considerations, various cell therapy modalities, regulatory considerations, methods for T cell expansion, biomarkers, adoptive immune therapies for melanoma, persistence of transferred cells, differentiation of human and mouse immune stem cells and clinical trials that will impact cell therapies from the perspective of Cancer Immunotherapy Trials Network (CITN).

Target Audience
The target audience for this program was basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research.

Presentations and video recordings are available based on permission from presenters.